OneDigital Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History

OneDigital Investment Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,562	Closed	-$253K	–	775
2021 Q2	$253K	Sell	1,562 -1,106	-41%	-$135K	0.01%	604
2021 Q1	$325K	Buy	2,668 +40	+2%	+$6.04K	0.02%	495
2020 Q4	$402K	Sell	2,628 -442	-14%	-$52.2K	0.02%	402
2020 Q3	$257K	Sell	3,070 -1,509	-33%	-$134K	0.02%	477
2020 Q2	$337K	Buy	+4,579	New	+$268K	0.02%	415
2020 Q1	–	Sell	-4,451	Closed	-$271K	–	576
2019 Q4	$271K	Buy	+4,451	New	+$243K	0.02%	440
2019 Q1	–	Sell	-1,500	Closed	-$43K	–	1133
2018 Q4	$43K	Buy	+1,500	New	+$52.1K	0.01%	489
2018 Q3	–	Sell	-100	Closed	-$6K	–	1064
2018 Q2	$6K	Buy	+100	New	+$5.7K	﹤0.01%	1138

Other funds holding CRSP

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

OneDigital Investment Advisors's CRSP Position: Q3 2021 in Review

OneDigital Investment Advisors sold out of CRISPR Therapeutics (CRSP) in Q3 2021, closing a stake of 1,562 shares — an estimated $253K sold.

OneDigital Investment Advisors first reported a position in CRSP in Q2 2018 and held it in 8 quarters. The position peaked at $402K in Q4 2020. 473 funds tracked by Wall St. Rank hold CRSP as of Q3 2021.

OneDigital Investment Advisors reported no remaining CRISPR Therapeutics position as of Q3 2021 after selling out during the quarter.
OneDigital Investment Advisors sold 1,562 CRISPR Therapeutics shares in Q3 2021, an estimated $253K.
OneDigital Investment Advisors first reported a position in CRISPR Therapeutics in Q2 2018 and held it in 8 quarters.
OneDigital Investment Advisors's CRISPR Therapeutics position peaked at $402K in Q4 2020.
473 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2021.

Based on OneDigital Investment Advisors's 13F filing for Q3 2021, filed 5 Nov 2021.